In Highlight
The Year in Cardiology 2027: Where Today’s Science Meets Tomorrow’s Care
Join leading experts for two days of cutting-edge science, clinical insights and global collaboration.
Discover event
Research
We fund and support scientific research to advance treatments and improve outcomes.
Education
We empower healthcare professionals with knowledge, training and best practices.
Global Impact
We work worldwide to ensure equitable access to quality heart failure care.
Better Lives
Our mission is simple: to save lives and improve heart health.
News
View all news →
Virtual Visits in Heart Failure: Mapping Use Before Judging Impact3 September 2025
Neighbourhood Deprivation and Heart Failure Outcomes: A Cohort Study24 June 2025Featured Videos
View all →
Latest Literature
View all →▤Predicting Incident Heart Failure: How Well Do Risk Models Validate?Research · 25 April 2026▤Biomarker-Guided Heart Failure Management: Why Certainty of Evidence MattersEvidence-Based Medicine · 17 April 2026▤HFpEF Pharmacotherapy: What a Network Meta-analysis ComparedCardiovascular Pharmacotherapy · 15 February 2026▤Dapagliflozin Started During Heart Failure Hospitalisation: DAPA ACT HF-TIMI 68Cardiovascular Pharmacotherapy · 4 December 2025
Upcoming Events
View all events →Latest Articles from PubMed
- Saponin extract from Astragalus membranaceus (Fisch.) Bunge regulates gut-brain axis through intestinal Escherichia coli to reduce cerebral oxidative stress to treat vascular dementia in rodents
- Bipolar Disorder and the Risk of Cardiovascular Diseases: A Systematic Review and Meta-Analysis of Observational Studies
- Development of the Readiness to Change Diet Questionnaire (RCdQ) for Assessing Willingness to Adopt Anti-Inflammatory Diet Among Coronary Artery Disease Patients
- Words That Heal: A Systematic Review of Healthcare Providers-Patient Communication to Enhance Chronic Care Management and Practice Recommendations
- Aspiration Thrombectomy for High-Risk Pulmonary Embolism With Life-Threatening Anemia and Active Uterine Bleeding: A Case Report
- Atorvastatin protects cardiomyocytes from doxorubicin toxicity by modulating YAP/TAZ signaling
